EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

OmpK36 deficiency and inducible AmpC β-lactamase synergistically drive imipenem resistance in Klebsiella aerogenes

Shumi Shang iD, Liyang Chen, Xiaosi Li, Siqi Xu, Heping Shen, Fuping Hu, Wenting Tang iD, Xiaoyan Wu iD

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.04108-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Shumi Shang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, the Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang Province, China. Hauptthemen laut MEDLINE: Imipenem, beta-Lactamases, Bacterial Proteins, Porins. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Second Affiliated Hospital of Jiaxing University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study systematically elucidates how ST88-KL186 Klebsiella aerogenes evolved carbapenem resistance through a dual synergistic mechanism involving porin deficiency and inducible AmpC β-lactamase, providing a mechanistic explanation for carbapenem resistance independent of carbapenemase production. From seven homologous strains (single-nucleotide polymorphism [SNP] difference 3–30) consecutively isolated from a patient with post-pancreaticoduodenectomy infection, three subsequent ascites isolates (R5–R7) developed carbapenem resistance after imipenem treatment. All strains carried the OmpK36 G138S mutation, which reduces pore diameter by ~15%, and displayed an inducible AmpC enzyme. However, an additional Q172Ter truncating mutation in OmpK36 was acquired exclusively in the resistant strains (R5–R7). Molecular dynamics simulations confirmed that the truncated protein loses conformational stability, resulting in a complete loss of functional porin. Although the susceptible strains already had a narrowed pore and inducible AmpC enzyme, residual porin function allowed enough drug entry to maintain susceptibility. In contrast, in resistant strains, loss of OmpK36 served as the primary barrier restricting drug entry, while the small amount of imipenem that entered was sufficient to induce high-level AmpC enzyme expression. The synergistic interplay between these two mechanisms: a “permeability barrier” coupled with “enzymatic hydrolysis”—ultimately overcame the carbapenem resistance threshold. This study underscores the importance of phenotypic screening for inducible AmpC enzymes in clinical practice and provides key evidence for optimizing the diagnosis and management of carbapenem-resistant Gram-negative bacteria. IMPORTANCE The synergistic resistance mechanism of OmpK36 deficiency and induced AmpC β-lactamase revealed in this study provides a critical theoretical supplement for understanding carbapenem resistance independent of carbapenemases. Structure-function analysis confirmed that the truncation mutation in OmpK36 in resistant strains leads to premature termination of translation and complete loss of the protein channel, thereby preventing drug entry into the cell while still triggering high expression of AmpC enzymes by the small amount of drug that does enter. The synergistic effect of these two mechanisms confers the carbapenem-resistant phenotype in Klebsiella aerogenes . This finding not only broadens our understanding of the evolution of adaptive bacterial resistance but also suggests that clinical microbiology laboratories should incorporate testing for this type of inducible AmpC enzyme into routine protocols, thereby providing direct evidence for precise identification of hidden resistance phenotypes and optimization of treatment regimens for severe infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Imipenembeta-LactamasesBacterial ProteinsPorinsAnti-Bacterial AgentsEnterobacter aerogenesHumansMicrobial Sensitivity TestsKlebsiella InfectionsMutationDrug Resistance, Bacterial

Stichwörter der Autor:innen

Klebsiella aerogenesOmpK36carbapenem resistanceinducible AmpC β-lactamase

Substanzen

Imipenembeta-LactamasesBacterial ProteinsPorinsAnti-Bacterial AgentsAmpC beta-lactamases

Autor:innen und Institutionen

  • Department of Laboratory Medicine, the Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang Province, China.
  • Department of Infectious Disease, the Second Affiliated Hospital of Jiaxing University, Jiaxing, China.
  • Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.

ORCID-Profile: Shumi Shang, Wenting Tang, Xiaoyan Wu

Förderung

  • the Second Affiliated Hospital of Jiaxing University

Zitieren

APA

Shang, S., Chen, L., Li, X., Xu, S., Shen, H., Hu, F., Tang, W., & Wu, X. (2026). OmpK36 deficiency and inducible AmpC β-lactamase synergistically drive imipenem resistance in Klebsiella aerogenes. Microbiology Spectrum. https://doi.org/10.1128/spectrum.04108-25

Vancouver

Shang S, Chen L, Li X, Xu S, Shen H, Hu F, et al. OmpK36 deficiency and inducible AmpC β-lactamase synergistically drive imipenem resistance in Klebsiella aerogenes. Microbiology Spectrum. 2026. doi:10.1128/spectrum.04108-25

BibTeX
@article{Shang2026,
  author = {Shang, Shumi and Chen, Liyang and Li, Xiaosi and Xu, Siqi and Shen, Heping and Hu, Fuping and Tang, Wenting and Wu, Xiaoyan},
  title = {OmpK36 deficiency and inducible AmpC β-lactamase synergistically drive imipenem resistance in Klebsiella aerogenes},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.04108-25}
}
Kostenlos starten →